tirzepatide summit trial In the trial, researchers examined cardiovascular outcomes of treatment with in patients with heart failure with preserved ejection fraction and obesity. Full results and Plain Language Summary: https://nej.md/4hRGaTY Medthreads Has Tirzepatide Scaled the HFpEF/Obesity

Quick Comparison : Key Takeaway : GLP-1 therapies may offer better weight loss and metabolic improvements, but side effects, cost, and access limit adherence

We know weight doesnt completely equal wellness

It is not a stimulant and it is not a substitute for healthy habits

For systemic anti-aging or cosmetic changes, studies often run for several months to observe measurable changes in biomarkers or skin elasticity

At present, it is not known whether the enhanced toxicity evident in rat and human liver slices when compared to mouse liver slices can be attributed to a species difference in formation of reactive intermediates, detoxification of these metabolites and/or to other considerations

If you or someone you know is taking these medications, it's crucial to understand the risks and have informed discussions with healthcare providers